Northern Trust Corp Marker Therapeutics, Inc. Transaction History

Northern Trust Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$1.68 - $2.88 $9,849 - $16,885	-5,863 Reduced 5.11%	108,830 $184,000
Q2 2021 Aug 13, 2021	SELL	$1.88 - $3.56 $414,286 - $784,499	-220,365 Reduced 65.77%	114,693 $320,000
Q1 2021 May 12, 2021	SELL	$1.47 - $3.29 $20,468 - $45,809	-13,924 Reduced 3.99%	335,058 $750,000
Q4 2020 Feb 11, 2021	BUY	$1.36 - $1.75 $9,858 - $12,685	7,249 Added 2.12%	348,982 $506,000
Q3 2020 Nov 16, 2020	SELL	$1.5 - $2.2 $42,234 - $61,943	-28,156 Reduced 7.61%	341,733 $513,000
Q2 2020 Aug 14, 2020	BUY	$1.69 - $2.79 $50,138 - $82,773	29,668 Added 8.72%	369,889 $766,000
Q1 2020 May 14, 2020	BUY	$1.59 - $3.35 $17,447 - $36,759	10,973 Added 3.33%	340,221 $647,000
Q4 2019 Feb 14, 2020	BUY	$2.68 - $4.85 $2,304 - $4,171	860 Added 0.26%	329,248 $948,000
Q3 2019 Nov 13, 2019	BUY	$4.1 - $9.0 $841,201 - $1.85 Million	205,171 Added 166.51%	328,388 $1.68 Million
Q2 2019 Aug 13, 2019	BUY	$5.15 - $7.92 $352,522 - $542,131	68,451 Added 124.99%	123,217 $976,000
Q1 2019 May 13, 2019	SELL	$5.1 - $6.71 $4,855 - $6,387	-952 Reduced 1.71%	54,766 $361,000
Q4 2018 Feb 12, 2019	BUY	$4.2 - $9.74 $234,015 - $542,693	55,718 New	55,718 $309,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $164M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.